The Royal Pharmaceutical Society (RPS) has reacted to the Community Pharmacy Contractual Framework (CPCF) that was announced for the year 2021/22 earlier today.
Thorrun Govind, Chair of the RPS English Pharmacy Board, said:
“There are some positive steps on supporting pharmacists’ clinical role, including blood pressure diagnosis, and the expansion of the New Medicines Service.
“We know that community pharmacy can play a key role in helping manage increasing demand on the NHS, but collaboration and support for implementation will be key to making new services a success.
“Pharmacists have been on the frontline throughout the pandemic. We are disappointed that the positive impact demonstrated by community pharmacy has not been recognised through increased investment. This is a real-terms funding cut delivered through the frozen core funding. Pharmacists working in community pharmacy will understandably be demoralised by this.
“Community pharmacy is an exciting and interesting place to work and pharmacists’ clinical skills must be utilised long-term. The greater use of Pharmacist Independent Prescribers to expand patient access to care will support this and we look forward to publication of more details on additional funding for training.”
Read more here.